Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 276.11M P/E - EPS this Y 3.50% Ern Qtrly Grth -
Income -128.91M Forward P/E -3.95 EPS next Y 16.40% 50D Avg Chg -12.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 21.00%
Dividend N/A Price/Book 4.11 EPS next 5Y - 52W High Chg -32.00%
Recommedations 2.00 Quick Ratio 3.47 Shares Outstanding 167.94M 52W Low Chg 168.00%
Insider Own 0.94% ROA -61.03% Shares Float 128.16M Beta 0.51
Inst Own 67.68% ROE -489.12% Shares Shorted/Prior 13.19M/12.33M Price 1.74
Gross Margin - Profit Margin - Avg. Volume 3,643,658 Target Price 4.12
Oper. Margin - Earnings Date Aug 8 Volume 1,671,654 Change 0.00%
About X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase II clinical trial to treat congenital, idiopathic, or cyclic neutropenia. The company is also developing X4P-003, a CXCR4 antagonist for the treatment of CXCR4 dependent disorders and primary immunodeficiencies; and X4P-002, a CXCR4 antagonist for the treatment of blood-brain barrier diseases. It has a license agreement with Abbisko Therapeutics Co Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications. The company is headquartered in Boston, Massachusetts.

X4 Pharmaceuticals, Inc. News
05/13/24 X4 Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
05/09/24 X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility
05/08/24 X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2024 Earnings Call Transcript
05/08/24 XFOR: Data from Phase 2 CN Trial Expected in June 2024…
05/08/24 X4 Pharmaceuticals Inc (XFOR) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
05/07/24 X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
05/01/24 X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/30/24 X4 Pharmaceuticals to Report First-Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 7, 2024
04/30/24 XFOR: XOLREMDI™ Approved by FDA…
04/29/24 UPDATE 1-US FDA approves X4 Pharmaceuticals' therapy for immunodeficiency disease
04/29/24 X4 Pharmaceuticals Announces FDA Approval of XOLREMDI™ (mavorixafor) Capsules, First Drug Indicated in Patients with WHIM Syndrome
04/11/24 X4 Pharmaceuticals, Inc.'s (NASDAQ:XFOR) market cap decline of US$42m may not have as much of an impact on institutional owners after a year of 7.0% returns
04/02/24 XFOR: PDUFA Date of April 30, 2024 for Mavorixafor for WHIM Syndrome…
04/01/24 X4 Pharmaceuticals to Participate in Upcoming April Investor Conferences
03/22/24 X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2023 Earnings Call Transcript
03/21/24 Q4 2023 X4 Pharmaceuticals Inc Earnings Call
03/21/24 X4 Pharmaceuticals Inc (XFOR) Reports Fourth-Quarter and Full-Year 2023 Financial Results
03/21/24 X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Corporate Update
03/12/24 X4 Pharmaceuticals to Report Fourth-Quarter and Full Year 2023 Financial Results and Host a Conference Call and Webcast on March 21, 2024
12/15/23 XFOR: Update on Phase 2 CN Trial at ASH 2023
XFOR Chatroom

User Image Night_Owl_Biotech Posted - 15 hours ago

The attachment notes the enterprise values paid KDMN, RETA & PRVB as multiples of the revenue forecasts prepared by the acquiree's management. All 3 were acquired within 2-5 months of FDA approval. At the bottom you'll see $MDGL enterprise value as multiples of analyst consensus revenue estimates per Seeking Alpha. Rezdiffra was approved 2 months ago. We have no idea if MDGL is about to be acquired, but you can see the upside if MDGL is acquired at multiples consistent with these peers. A reminder, enterprise value is different than market cap (upside is not necessarily proportional). $DAWN $SWTX $IOVA & $XFOR also have recent approvals

User Image jessejamez Posted - 1 day ago

$XFOR bright green next week! LG 🤘🏴‍☠️

User Image SocioCobb Posted - 1 day ago

$XFOR 2nd add .92 AH, 50% of position filled. Mark 👀

User Image Ramus1 Posted - 1 day ago

$XFOR There should be a criminal investigation into this company,too bad we don't have an SEC anymore

User Image Jmk1979 Posted - 1 day ago

$XFOR I guess it was not about the options 🥺

User Image Rlad Posted - 1 day ago

$XFOR - added at $.90… thank you for the fill!

User Image edon5 Posted - 2 days ago

$XFOR shares are HTB .. was 5 mil + recently...

User Image Jmk1979 Posted - 2 days ago

$XFOR the buy zone is from 0.87-0.80 dolares just avarage down from there and hopefully we go up from there

User Image DS121212 Posted - 2 days ago

$XFOR wild stuff. Please keep telling me that news and charts mean anything. All just random action.

User Image CliffordCapital Posted - 2 days ago

@Bionco you said the same at $XFOR and then +50% in three days 🙈😂

User Image Genco Posted - 2 days ago

$XFOR Even if I make 10 times the money from this damn company, I will continue to hate it. Damn the day I invested. This manulupasuon will save us all from health..🤬🤬🤬🤬🤬

User Image Rollercoaster22 Posted - 2 days ago

$XFOR Does this ticker have any bottom?

User Image boomshiva Posted - 2 days ago

$XFOR Someone explain to me how we lost 15% in mc after adding $125 mill to the balance sheet.

User Image Jmk1979 Posted - 2 days ago

$XFOR Doesn't look good in my opinion If we all re not moving by Monday I'll wait to jump in

User Image TheGunnerAB Posted - 2 days ago

So $DAWN gets an FDA approval and a PVR. A week later, $XFOR gets approval and a PVR. $XFOR sells their PVR a few days later for $105M. Why didn't $DAWN sell their PVR? For internal use or maybe part of a much bigger move.

User Image tcoffaro Posted - 2 days ago

$XFOR does anyone know what day the investor event in June ? or is that the "million dollar question" ?

User Image HoneyBadgerOnTheRun Posted - 3 days ago

$XFOR on watch, needs volume

User Image Jmk1979 Posted - 3 days ago

$XFOR Another red day 🥺

User Image DS121212 Posted - 4 days ago

$XFOR Everything green and setting records except for the ticker with a bunch of positive news. Makes sense. #NothingMeansAnything

User Image Trancehead75 Posted - 4 days ago

$XFOR H.C. Wainwright 2nd Annual BioConnect Investor Conference MAY 20, 2024 AT 2:00 PM EDT - Was anybody able to come across their abstract? If so, I'm assuming it's in relation to XOLREMDI and WHIM...If not, I'm wondering if they may drop their phase 2 CND data during the event.

User Image AG_Trader1 Posted - 5 days ago

$XFOR Burning the options up

User Image Pangloss_0589 Posted - 5 days ago

$XFOR if this was indeed about options I would suppose that we will remain stuck between 0.97 -1.005 $ until friday close

User Image Tanny86 Posted - 5 days ago

$XFOR Not sure what's going on they sold PRV already $105 million.

User Image Falstaff Posted - 5 days ago

$XFOR just added. Now at 10,000 shares at .7775

User Image Jmk1979 Posted - 5 days ago

$XFOR

User Image Outrageous Posted - 5 days ago

$XFOR X4 Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference May 13, 2024 https://investors.x4pharma.com/news-releases/news-release-details/x4-pharmaceuticals-participate-hc-wainwright-2nd-annual

User Image Pharmer23 Posted - 5 days ago

$XFOR starter here . Went in pretty heavy though. Drop doesn’t really make sense . See how this done in June

User Image Capitulation_0 Posted - 5 days ago

$XFOR be weary of crowded stocks.. Twitter has been pumping this for a while now..

User Image KiwiTraveller Posted - 5 days ago

$IBRX - Nice moves today - am long till at least $12 and even then will hold half years $APPS - moving up next week into earnings - will pick up 10k more shares either before or after ER depending where is next Monday $XFOR will be doubling share count here after can trim some others in next day or two $ALLR Not a huge position and holding for news, not adding or trimming till it decides which way its going - have SL

User Image AG_Trader1 Posted - 5 days ago

$XFOR Think this is to wipe out options. Hopefully this pins around $1 for a week and the sell off stops.

Analyst Ratings
HC Wainwright & Co. Buy Apr 30, 24
HC Wainwright & Co. Buy Mar 22, 24
B. Riley Securities Neutral Dec 12, 23
HC Wainwright & Co. Buy Aug 11, 23
Stifel Buy May 17, 23
HC Wainwright & Co. Buy May 5, 23
B. Riley Securities Buy Apr 10, 23
Oppenheimer Outperform Mar 24, 23
Cantor Fitzgerald Overweight Mar 22, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Ragan Paula President and CEO President and CEO Nov 01 Sell 0.82 239,437 196,338 836,441 11/03/23
WYZGA MICHAEL S Director Director Aug 18 Buy 1.195 25,000 29,875 76,667 08/22/23
Stewart Murray Interim Chief Medica.. Interim Chief Medical Officer Aug 09 Sell 1.06 130,056 137,859 146,504 08/11/23
Ragan Paula President and CEO President and CEO May 31 Sell 1.95 6,292 12,269 557,245 05/31/23
Ragan Paula President and CEO President and CEO Jun 03 Sell 1.21 6,292 7,613 661,806 06/06/22